Centuple Global Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 510537,
    "name": "Centuple Global",
    "stock_name": "Centuple Global",
    "full_name": "Centuple Global Ltd",
    "name_url": "stocks-analysis/centuple-global",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "37.76",
    "chg": 1.32,
    "chgp": "3.62%",
    "dir": 1,
    "prev_price": "36.44",
    "mcapval": "20.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531099,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE396H01019",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "2.07 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/centuple-global-510537-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Checkpoint Trends Ltd Downgraded to Sell Amid Institutional Exit Despite Strong Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-downgraded-to-sell-amid-institutional-exit-despite-strong-financials-3953338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_mojoScore_3953338.png",
        "date": "2026-04-20 08:08:53",
        "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Apr 2026. Despite strong financial performance and attractive valuation metrics, concerns over institutional participation and technical indicators have weighed on the outlook, prompting a reassessment of the stock’s prospects."
      },
      {
        "title": "Checkpoint Trends Ltd Gains 17.44%: 2 Key Factors Driving the Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/checkpoint-trends-ltd-gains-1744-2-key-factors-driving-the-move-3952641",
        "imagepath": "",
        "date": "2026-04-18 17:03:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 13:</strong> Upgrade to Hold rating as technicals and financials improve</p>\n                    <p><strong>Apr 15:</strong> Stock jumps 5.00% amid strong volume</p>\n                    <p><strong>Apr 16:</strong> Continued gains with 4.99% rise</p>\n                    <p><strong>Apr 17:</strong> Death Cross formation signals potential bearish trend</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.52.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.61.36</div><div class=\"stat-..."
      },
      {
        "title": "Checkpoint Trends Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/checkpoint-trends-ltd-forms-death-cross-signalling-potential-bearish-trend-3951636",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_dealthcross_3951636.png",
        "date": "2026-04-17 18:00:15",
        "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock's medium to long-term momentum despite its recent volatile performance."
      },
      {
        "title": "Checkpoint Trends Ltd Upgraded to Hold as Technicals and Financials Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-upgraded-to-hold-as-technicals-and-financials-improve-3944144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_mojoScore_3944144.png",
        "date": "2026-04-13 08:09:00",
        "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 10 April 2026. This change reflects a combination of improved technical indicators, robust financial performance, attractive valuation metrics, and a positive quality assessment, signalling a cautious but optimistic outlook for investors."
      }
    ],
    "total": 10,
    "sid": "510537",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/centuple-global-510537"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Jun-2026",
      "details": "Newspaper publication",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Result For The Quarter And Year Ended March 31 2026",
      "datetime": "30-May-2026",
      "details": "Audited financial result for the quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "30-May-2026",
      "details": "Outcome of Board Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Checkpoint Trends Ltd Downgraded to Sell Amid Institutional Exit Despite Strong Financials

2026-04-20 08:08:53

Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Apr 2026. Despite strong financial performance and attractive valuation metrics, concerns over institutional participation and technical indicators have weighed on the outlook, prompting a reassessment of the stock’s prospects.

Checkpoint Trends Ltd Gains 17.44%: 2 Key Factors Driving the Move

2026-04-18 17:03:53

Key Events This Week Apr 13: Upgrade to Hold rating as technicals and financials improve Apr 15: Stock jumps 5.00% amid strong volume Apr 16: Continued gains with 4.99% rise Apr 17: Death Cross formation signals potential bearish trend Week OpenRs.52.25 Week CloseRs.61.36<div class="stat-...

Checkpoint Trends Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-04-17 18:00:15

Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock's medium to long-term momentum despite its recent volatile performance.

Checkpoint Trends Ltd Upgraded to Hold as Technicals and Financials Improve

2026-04-13 08:09:00

Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 10 April 2026. This change reflects a combination of improved technical indicators, robust financial performance, attractive valuation metrics, and a positive quality assessment, signalling a cautious but optimistic outlook for investors.

View All News